Cargando…

The Effects of Thiazolidinediones on Metabolic Complications and Lipodystrophy in HIV-Infected Patients

Highly active antiretroviral therapy (HAART)-associated metabolic complications include lipoatrophy (loss of subcutaneous adipose tissue (SAT)) and insulin resistance. Thiazolidinediones are insulin-sensitizing antidiabetic agents which—as an untoward side effect in obese diabetic patients—increase...

Descripción completa

Detalles Bibliográficos
Autor principal:	Sutinen, Jussi
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2009
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2593088/ https://www.ncbi.nlm.nih.gov/pubmed/19096512 http://dx.doi.org/10.1155/2009/373524

Ejemplares similares

Lipodystrophy and metabolic syndrome in Romanian HIV-infected adults
por: Arbune, M
Publicado: (2010)

Impact of Lipodystrophy on the prevalence and components of metabolic syndrome in HIV-infected patients
por: Freitas, Paula, et al.
Publicado: (2011)

New and emerging agents in the management of lipodystrophy in HIV-infected patients
por: Bonnet, Eric
Publicado: (2010)

MON-695 Multiple Recurrent Lipomatoses with Thiazolidinedione Therapy in Familial Partial Lipodystrophy, Dunnigan Variety (FPLD2)
por: Patni, Nivedita, et al.
Publicado: (2020)

Biochemical Manifestation of HIV Lipodystrophy Syndrome
por: Ihenetu, Kenneth, et al.
Publicado: (2012)

Lipodystrophy in HIV patients: its challenges and management approaches
por: Singhania, Rohit, et al.
Publicado: (2011)

Uridine Metabolism in HIV-1-Infected Patients: Effect of Infection, of Antiretroviral Therapy and of HIV-1/ART-Associated Lipodystrophy Syndrome
por: Domingo, Pere, et al.
Publicado: (2010)

Chemotherapy and Chemoprevention by Thiazolidinediones
por: Fröhlich, Eleonore, et al.
Publicado: (2015)

Thiazolidinediones and Edema: Recent Advances in the Pathogenesis of Thiazolidinediones-Induced Renal Sodium Retention
por: Horita, Shoko, et al.
Publicado: (2015)

Approach to Dyslipidemia, Lipodystrophy, and Cardiovascular Risk in Patients with HIV Infection
por: Troll, J. Gregory
Publicado: (2010)

The metabolic syndrome, thiazolidinediones, and implications for intersection of chronic and inflammatory disease
por: Colca, Jerry R., et al.
Publicado: (2021)

Leptin in Relation to the Lipodystrophy-Associated Metabolic Syndrome
por: Mantzoros, Christos S.
Publicado: (2012)

Effects of Thiazolidinedione and New Antidiabetic Agents on Stroke
por: Ahn, Chang Ho, et al.
Publicado: (2019)

Body composition and lipodystrophy in prepubertal HIV-infected children
por: Palchetti, Cecilia Zanin, et al.
Publicado: (2013)

Role of Mitochondria in HIV Infection and Associated Metabolic Disorders: Focus on Nonalcoholic Fatty Liver Disease and Lipodystrophy Syndrome
por: Pérez-Matute, P., et al.
Publicado: (2013)

Effects of Three Thiazolidinediones on Metabolic Regulation and Cold-Induced Thermogenesis
por: Sohn, Jee Hyung, et al.
Publicado: (2018)

Growth hormone and tesamorelin in the management of HIV-associated lipodystrophy
por: Bedimo, Roger
Publicado: (2011)

Comparison of Dorsocervical With Abdominal Subcutaneous Adipose Tissue in Patients With and Without Antiretroviral Therapy–Associated Lipodystrophy
por: Sevastianova, Ksenia, et al.
Publicado: (2011)

A review of thiazolidinediones and metformin in the treatment of type 2 diabetes with focus on cardiovascular complications
por: Behzad, Molavi, et al.
Publicado: (2007)

Challenges in Managing Metabolic Complications in a Patient With Familial Partial Lipodystrophy Type 3
por: Shah, Kajal, et al.
Publicado: (2021)

Adiponectin and leptin levels in HIV-infected patients with lipodystrophy in Southern India
por: Jacob, S Mini, et al.
Publicado: (2010)

Comparison of the Effects of Metformin and Thiazolidinediones on Bone Metabolism: A Systematic Review and Meta-Analysis
por: Chen, Ru-Dong, et al.
Publicado: (2023)

Therapeutic Actions of the Thiazolidinediones in Alzheimer's Disease
por: Pérez, María José, et al.
Publicado: (2015)

Antiretroviral-Related Adipocyte Dysfunction and Lipodystrophy in HIV-Infected Patients: Alteration of the PPARγ-Dependent Pathways
por: Caron, Martine, et al.
Publicado: (2009)

Psychopathology and psychosocial adjustment in patients with HIV-associated lipodystrophy
por: Barata, Anna, et al.
Publicado: (2013)

Thiazolidinediones are partially effective bitter blockers
por: Nguyen, Ha, et al.
Publicado: (2023)

Body Composition and Metabolic Syndrome Components on Lipodystrophy Different Subtypes Associated with HIV
por: Sacilotto, Livia Bertazzo, et al.
Publicado: (2017)

Thiazolidinediones and bone fractures
por: Kaku, Kohei, et al.
Publicado: (2011)

Biological potential of thiazolidinedione derivatives of synthetic origin
por: Sucheta, et al.
Publicado: (2017)

Prevalence of lipodystrophy and risk factors for dyslipidemia in HIV-infected children in Brazil
por: Papi, Luanda, et al.
Publicado: (2014)

Cardiac Alterations in Patients with Familial Lipodystrophy
por: Romano, Minna Moreira Dias, et al.
Publicado: (2020)

HIV-associated lipodystrophy: a review from a Brazilian perspective
por: Alves, Marcelle D, et al.
Publicado: (2014)

Investigation of SIRT1 gene variants in HIV-associated lipodystrophy and metabolic syndrome
por: Tagliari, Carmela Farias da Silva, et al.
Publicado: (2020)

Thiazolidinediones and Fertility in Polycystic Ovary Syndrome (PCOS)
por: Froment, Pascal, et al.
Publicado: (2006)

Thiazolidinediones on PPARγ: The Roles in Bone Remodeling
por: Wei, Wei, et al.
Publicado: (2011)

HIV/AIDS and lipodystrophy: Implications for clinical management in resource-limited settings
por: Finkelstein, Julia L, et al.
Publicado: (2015)

Beneficial effects of physical activity in an HIV-infected woman with lipodystrophy: a case report
por: Mendes, Edmar Lacerda, et al.
Publicado: (2011)

Lipodystrophy: Still an underdiagnosed complication of subcutaneous insulin administration
por: Barbosa, Mariana, et al.
Publicado: (2022)

Nutritional and metabolic status of HIV-positive patients with lipodystrophy during one year of follow-up
por: dos Anjos, Eloísa Marchi, et al.
Publicado: (2011)

Potential Therapeutic Effects of Thiazolidinedione on Malignant Glioma
por: Sheu, Meei-Ling, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rdu6i43cfvlq86225qpsqimkot